![](/img/cover-not-exists.png)
A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings
KANE, G, POLLICE, M, KIM, C, COHN, J, DWORSKI, R, MURRAY, J, SHELLER, J, FISH, J, PETERS, SVolume:
97
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/s0091-6749(96)70310-x
Date:
February, 1996
File:
PDF, 928 KB
english, 1996